NCT05257408Phase 3Active not recruiting

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

Study sponsor: Corcept Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-03-31Actual
Enrollment · participants381Actual
Source updated2026-09-25Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Progression-free Survival as Assessed by BICR Description: Time from randomization until the time of first documented progressive disease (PD) by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, or death due to any cause, whichever occurs first Time frame: Up to 24 months from enrollment of the last patient Measure: Overall survival Description: Time from randomization to death by any cause Time frame: Up to 24 months from enrollment of the last patient. After: Measure: Progression-free Survival (PFS) as Assessed by Blinded Independent Central Review (BICR) Description: PFS was assessed as the time from randomization until the time of first documented progressive disease (PD) or death due to any cause, whichever occurs first. Progression is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST v1.1), as a 20% increase in the sum of the longest diameter of target lesions, or an unequivocal progression in a non-target lesion, or the appearance of new lesions. Time frame: Up to 20 months Measure: Overall Survival Description: Overall survival (OS) was assessed as the time from randomization to death by any cause. The data values are Kaplan-Meier estimates. Time frame: Up to 32 months.

Primary completion date changed

Before: 24 Mar 2025. After: 31 Mar 2025.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview